gadofosveset trisodium has been researched along with Cardiovascular Diseases in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deng, J; Johnson, JT; Rigsby, CK; Robinson, JD | 1 |
Brown, J; Farooki, A; Narra, V | 1 |
Bekkers, SC; Gerretsen, SC; Leiner, T; Versluis, B | 1 |
de Roos, A; Kroft, LJ | 1 |
Mahfouz, AE | 1 |
2 review(s) available for gadofosveset trisodium and Cardiovascular Diseases
Article | Year |
---|---|
Gadofosveset (EPIX/Schering).
Topics: Animals; Capillary Permeability; Cardiovascular Diseases; Clinical Trials as Topic; Contrast Media; Gadolinium; Humans; Inflammation; Neoplasms; Organometallic Compounds | 2004 |
Blood pool contrast agents for cardiovascular MR imaging.
Topics: Cardiovascular Diseases; Contrast Media; Dextrans; Ferrosoferric Oxide; Gadolinium; Humans; Iron; Macromolecular Substances; Magnetic Resonance Angiography; Magnetite Nanoparticles; Organometallic Compounds; Oxides | 1999 |
3 other study(ies) available for gadofosveset trisodium and Cardiovascular Diseases
Article | Year |
---|---|
Combined blood pool and extracellular contrast agents for pediatric and young adult cardiovascular magnetic resonance imaging.
Topics: Adolescent; Adult; Cardiovascular Diseases; Child; Child, Preschool; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Heart Defects, Congenital; Humans; Image Enhancement; Infant; Infant, Newborn; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Retrospective Studies | 2016 |
Cardiac cine MRI: comparison of 1.5 T, non-enhanced 3.0 T and blood pool enhanced 3.0 T imaging.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Organometallic Compounds; Statistics, Nonparametric | 2008 |
MS-325 EPIX.
Topics: Animals; Breast Neoplasms; Cardiovascular Diseases; Clinical Trials as Topic; Contraindications; Contrast Media; Drugs, Investigational; Female; Gadolinium; Humans; Muscular Dystrophies; Organometallic Compounds | 2000 |